Lupeol suppresses cisplatin-induced nuclear factor-κB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model

Cancer Research

Volumn 67, Issue 18, 2007, Pages 8800-8809

  Lee, Terence K ^a   Poon, Ronnie T P ^a   Wo, Jana Y ^a   Ma, Stephanie ^a   Guan, Xin Yuan ^a   Myers, Jeffrey N ^b   Altevogt, Peter ^c   Yuen, Anthony P W ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TEXAS   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUPEOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CANCER MODEL; CELL LINE; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FIBROBLAST; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CELL DEATH; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; DOWN-REGULATION; DRUG SYNERGISM; EPITHELIAL CELLS; HEAD AND NECK NEOPLASMS; HUMANS; I-KAPPA B KINASE; LYMPHATIC METASTASIS; MESODERM; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NF-KAPPA B; TRANSFECTION; TRITERPENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34548763142     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0801     Document Type: Article

References (45)

1. Boring C, Squire TS, Tong T. Cancer statistics. CA Cancer J Clin 1992;42:19-38.
2. Vokes EE, Wechselbaum RR, Lippman SM, et al. Head and neckcancer. N Engl J Med 1993;328:184-94.
3. Reis L, Eisner M, Kosary C, et al. Cancer statistics review, 1973-1998. Bethesda (MD): National Cancer Institute; 2001.
4. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity [review]. Semin Oncol 2004;31:744-54.
5. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.
6. Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990;50:6502-7.
7. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985;64:111-26.
8. Mufti SI, Eskelson CD, Odeleye OE, et al. Alcohol-associated generation of oxygen free radicals and tumor promotion. Alcohol Alcohol 1993;28:621-8.
9. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994;54:1890-4S.
10. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A 1995;92:5258-65.
11. Winn DM, Ziegler RG, Pickle LW, et al. Diet in the etiology of oral and pharyngeal cancer among women from the southern United States. Cancer Res 1984;44:1216-22.
12. McLaughlin JK, Gridley G, Block G, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80:1237-43.
13. Sarkar FH, Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 2004;555:53-64.
14. Kinghorn AD, Su BN, Jang DS, et al. Natural inhibitors of carcinogenesis. Planta Med 2004;70:691-705.
15. Saleem M, Adhami VM, Siddiqui IA, et al. Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer 2003;47:13-23.
16. Saleem M, Afaq F, Adhami VM, et al. Lupeol modulates NF-B and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004;23:5203-14.
17. Saleem M, Kweon MH, Yun JM, et al. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res 2005;65:11203-13.
18. Saleem M, Alam A, Arifin S, et al. Lupeol, a triterpene, inhibits early responses of tumor promotion induced by benzoyl peroxide in murine skin. Pharm Res 2001;43:127-34.
19. Geetha T, Varalakshmi P. Anti-inflammatory activity of lupeol and lupeol linoleate in rats. J Ethnopharmacol 2001;76:77-80.
20. Hasmeda M, Kweifio-Okai G, Macrides T, et al. Selective inhibition of eukaryote protein kinases by anti-inflammatory triterpenoids. Planta Med 1999;65:14-8.
21. Hodges LD, Kweifio-Okai G, Macrides TA. Antiprotease effect of anti-inflammatory lupeol esters. Mol Cell Biochem 2003;252:97-101.
22. Hata K, Hori K, Takahashi S. Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. J Nat Prod 2002;65:645-8.
23. Aratanechemuge Y, Hibasami H, Sanpin K, et al. Induction of apoptosis by lupeol isolated from mokumen (Gossampinus malabarica L. Merr) in human promyelotic leukemia HL-60 cells. Oncol Rep 2004;11:289-92.
24. Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neckcancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004;15:1179-86.
25. Szakacs G, Annereau JP, Lababidi S, et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 2004;6:129-37.
26. Samimi G, Fink D, Varki NM, et al. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin Cancer Res 2000;6:1415-21.
27. Boudsocq F, Benaim P, Canitrot Y, et al. Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase β. Mol Pharmacol 2005;67:1485-92.
28. Venkatraman M, Anto RJ, Nair A, et al. Biological and chemical inhibitors of NF-κB sensitize SiHa cells to cisplatin-induced apoptosis. Mol Carcinog 2005;44:51-9.
29. Myers JN, Holsinger FC, Jasser SA, et al. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 2002;8:293-8.
30. Chan CF, Yau TO, Jin DY, et al. Evaluation of nuclear factor-κB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin Cancer Res 2004;10:4140-9.
31. Lee TK, Man K, Poon RT, et al. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res 2006;66:9948-56.
32. Lee TK, Man K, Ho JW, et al. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res 2005;11:8458-66.
33. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 1999;68:459-86.
34. Yoshioka K, Nakamori S, Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999;59:2004-10.
35. Banyard J, Nand-Apte B, Symons M, et al. Motility and invasion are differentially modulated by Rho family GTPases. Oncogene 2000;19:580-91.
36. Takeichi M. Cadherins in cancer: implications for invasion andmetastasis. Curr Opin Cell Biol 1993;5:806-11.
37. Bracke ME, Van Roy FM, Mareel MM. The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 1996;213:123-61.
38. Birchmeier W, Behrsens J, Weidner KM, et al. Epithelial differentiation and the control of metastasis in carcinomas. Curr Top Microbiol Immunol 1996;213:117-35.
39. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products. Cancer Res 2007;67:3857-61.
40. Li N, Chen X, Liao J, Yang G, et al. Inhibition of 7,12- dimethylbenz(a)anthrsacene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 2002;23:1307-13.
41. Deeb D, Xu YX, Jiang H, et al. Curcumin (diferuloylmethane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2003;2:95-103.
42. Lo Tempio MM, Veena MS, Steele Hl, et al. Curcumin suppresses growth of head and necksquam ous cell carcinoma. Clin Cancer Res 2005;11:6994-7002.
43. Bremne P, Heinrich M. Natural products as targeted modulators of the nuclear factor-κB pathway [review]. J Pharm Pharmacol 2002;54:453-72.
44. Ruggeri EM, Carlini P, Pollera CF, et al. Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery. Head Neck 2005;27:452-8.
45. Soo K, O'Rourke MP, Khoo PL, et al. Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. Dev Biol 2002;247:251-70.